• M A Bouderka, A Nsiri, A Bouhouri, A Bouaggad, R Alharrar, and D Hamoudi.
• Service d'anesthésie-réanimation des urgences chirurgicales (P33), CHU Ibn Rochd, Casablanca, Maroc. Electronic address: mabouderka@yahoo.fr.
• Ann Fr Anesth Reanim. 2014 Jan 1;33(1):21-5.

ObjectiveTo determine current clinical neuromuscular use in Morocco anesthetic practice.Study DesignClinical practice survey.MethodsAnesthesiologists were invited to answer anonymously to question about neuromuscular blocking agents (NMBA): pharmacology, monitoring and antagonism drug use. Corrected yates test was used to compare qualitative parameters and variance analysis for quantitative parameters. P<0.05 was considered as significant.ResultsWe had 171 answers, 54% were paramedics (n=93) and 46% (n=78) were physicians (20% global effective in Morocco). Fifty-five percent were seniors. Vecuronium was the most NMBA used in Morocco for 51% of the anesthesiologists. Mean action time of NMBA was underestimate in more than 60% of the staff questioned specially for seniors (24.6%) than juniors (19.2%). Residual neuromuscular blockade was evaluated only by clinical and spirometric parameters in 72%. TOF monitor was used in 18% more in military hospitals (36%) and insurance clinics (40%) than private hospitals (12.5%). Administration of reversal drugs was systematic in 5.8% of anesthesiologists, frequent for 36.3% and rare for 55%.ConclusionsThis study show an underestimation of residual neuromuscular blockade, poor neuromuscular monitor use and lack of knowledge of NMBA specially for senior anesthesiologists and in private hospitals. We should elaborate Moroccan guideline for NMBA use and provide formal training programs for our anesthetic staff.Copyright © 2013 Société française d’anesthésie et de réanimation (Sfar). Published by Elsevier SAS. All rights reserved.

26 keywords...

hide…